Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Boender

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Blood|November 25, 2017
Low VWF: an established mild bleeding disorder?Frank W G Leebeek, Johan Boender
Thrombosis and Haemostasis|August 18, 2020
Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNAAnnika de Jong, Richard J Dirven, Johan Boender, et al.
Blood Advances|December 14, 2019
von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWDFerdows Atiq, Lisette M Schütte, Agnes E M Looijen, et al.
Scientific Reports|April 5, 2018
Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based studyFrank J Wolters, Johan Boender, Paul S de Vries, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 8, 2016
von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort StudySanaz Sedaghat, Paul S de Vries, Johan Boender, et al.
Blood|May 3, 2015
Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activityPaul S de Vries, Johan Boender, Michelle A H Sonneveld, et al.
Thrombosis Research|September 22, 2015
Theme 1: Pathogenesis of venous thromboembolism (and post-thrombotic syndrome)Paola E J van der Meijden, Yukio Ozaki, Wolfram Ruf, et al.
American Journal of Hematology|September 17, 2015
Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleedingYvonne V Sanders, Karin Fijnvandraat, Johan Boender, et al.
Hemasphere|February 24, 2021
Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand DiseaseJohan Boender, Ferdows Atiq, Marjon H Cnossen, et al.
Research and Practice in Thrombosis and Haemostasis|December 14, 2020
ADAMTS-13 and bleeding phenotype in von Willebrand diseaseJohan Boender, Angelique Nederlof, Karina Meijer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood|November 25, 2017
Low VWF: an established mild bleeding disorder?Frank W G Leebeek, Johan Boender
Thrombosis and Haemostasis|August 18, 2020
Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNAAnnika de Jong, Richard J Dirven, Johan Boender, et al.
Blood Advances|December 14, 2019
von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWDFerdows Atiq, Lisette M Schütte, Agnes E M Looijen, et al.
Scientific Reports|April 5, 2018
Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based studyFrank J Wolters, Johan Boender, Paul S de Vries, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 8, 2016
von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort StudySanaz Sedaghat, Paul S de Vries, Johan Boender, et al.
Blood|May 3, 2015
Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activityPaul S de Vries, Johan Boender, Michelle A H Sonneveld, et al.
Thrombosis Research|September 22, 2015
Theme 1: Pathogenesis of venous thromboembolism (and post-thrombotic syndrome)Paola E J van der Meijden, Yukio Ozaki, Wolfram Ruf, et al.
American Journal of Hematology|September 17, 2015
Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleedingYvonne V Sanders, Karin Fijnvandraat, Johan Boender, et al.
Hemasphere|February 24, 2021
Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand DiseaseJohan Boender, Ferdows Atiq, Marjon H Cnossen, et al.
Research and Practice in Thrombosis and Haemostasis|December 14, 2020
ADAMTS-13 and bleeding phenotype in von Willebrand diseaseJohan Boender, Angelique Nederlof, Karina Meijer, et al.
Pageof 2